These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7466730)

  • 21. Thyroid hormone and thyrotropin levels in patients placed on colestipol hydrochloride.
    Witztum JL; Jacobs LS; Schonfeld G
    J Clin Endocrinol Metab; 1978 May; 46(5):838-40. PubMed ID: 262768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colestipol in familial type II hyperlipoproteinemia: a three-year trial.
    Harvengt C; Desager JP
    Clin Pharmacol Ther; 1976 Sep; 20(3):310-4. PubMed ID: 182429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of colestipol therapy in Type II hyperlipoproteinemia.
    Lees AM; McCluskey MA; Lees RS
    Atherosclerosis; 1976; 24(1-2):129-40. PubMed ID: 182181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia.
    Kuo PT; Hayase K; Kostis JB; Moreyra AE
    Circulation; 1979 Feb; 59(2):199-211. PubMed ID: 215338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regression of coronary atherosclerosis in man.
    Myant NB
    Adv Exp Med Biol; 1984; 168():139-52. PubMed ID: 6375296
    [No Abstract]   [Full Text] [Related]  

  • 26. [Long-term effects of a glycosaminoglycan on plasma lipids].
    Avogaro P; Bittolo-Bon G; Alessandrini P
    Clin Ter; 1981 Jul; 98(1):47-61. PubMed ID: 7249572
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of hypolipidemic therapy on cholesterol homeostasis in freshly isolated mononuclear cells from patients with heterozygous familial hypercholesterolemia.
    Sundberg EE; Illingworth DR
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7631-5. PubMed ID: 6584876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased plasma fibrinogen and platelet-aggregates in type II hyperlipoproteinaemia.
    Lowe GD; Drummond MM; Third JL; Bremner WF; Forbes CD; Prentice CR; Lawrie TD
    Thromb Haemost; 1980 Feb; 42(5):1503-7. PubMed ID: 7368154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fat-soluble vitamin concentrations in hypercholesterolemic children treated with colestipol.
    Schwarz KB; Goldstein PD; Witztum JL; Schonfeld G
    Pediatrics; 1980 Feb; 65(2):243-50. PubMed ID: 7354970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serum cholesterol and triglyceride levels in patients with type II hyperlipoproteinemia treated with probucol].
    Markiewicz M; Rymar B; Horubała-Bielak G; Koziara Z
    Wiad Lek; 1984 Oct; 37(19):1489-93. PubMed ID: 6528586
    [No Abstract]   [Full Text] [Related]  

  • 31. [Etiroxate treatment for hyperlipoproteinaemia type IIa and IIb (author's transl)].
    Zadák Z; Kalinová M; Sobotka L
    Cas Lek Cesk; 1982 May; 121(19):593-5. PubMed ID: 7093991
    [No Abstract]   [Full Text] [Related]  

  • 32. Colestipol hydrochloride for treatment of hypercholesterolemia in a family practice: five-year study.
    Ruoff G
    J Am Geriatr Soc; 1978 Mar; 26(3):121-6. PubMed ID: 624819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Type II hyperlipoproteinaemia treated with etiroxate (author's transl)].
    Vondra K; Válek J; Dobiásová M; Honzák R
    Cas Lek Cesk; 1979 Oct; 118(40-41):1251-5. PubMed ID: 527004
    [No Abstract]   [Full Text] [Related]  

  • 34. Extracranial carotid arterial disease in patients with familial hypercholesterolemia and coronary artery disease treated with colestipol and nicotinic acid.
    Kuo PT; Toole JF; Schaaf JA; Jones A; Wilson AC; Kostis JB; Moreyra AE
    Stroke; 1987; 18(4):716-21. PubMed ID: 3299882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cholesterol and triglyceride plasma levels in patients with primary hyperlipoproteinemia. Decline after short-term i.v. glucagon administration].
    Andĕl M; Brodan V; Kucerová L; Grafnetter D; Kuhn E; Veselková A
    Cas Lek Cesk; 1980 May; 119(22):616-21. PubMed ID: 7427980
    [No Abstract]   [Full Text] [Related]  

  • 36. Colestipol hydrochloride in hypercholesterolemic patients--effect on serum cholesterol and mortality.
    Dorr AE; Gundersen K; Schneider JC; Spencer TW; Martin WB
    J Chronic Dis; 1978 Jan; 31(1):5-14. PubMed ID: 346598
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical study on the effect of simvastatin on butyrylcholinesterase activity.
    Muacević-Kataneca D; Bradamante V; Reinec Z; Sucić M; Poljicanin T; Busljeta I; Metelko Z
    Arzneimittelforschung; 2005; 55(5):271-5. PubMed ID: 15960426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Colestipol by hypercholesteremia in diabetics].
    Düntsch G
    Fortschr Med; 1977 Jun; 95(22):1492-6. PubMed ID: 873435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response of hyperlipoproteinemia to colestipol.
    Sachs BA; Wolfman L
    N Y State J Med; 1973 May; 73(9):1068-70. PubMed ID: 4512165
    [No Abstract]   [Full Text] [Related]  

  • 40. Cholesterol-lowering effect of colestipol hydrochloride given twice daily in hypercholesterolemic patients.
    Gundersen K; Cooper EE; Ruoff G; Nikolai T; Assenzo JR
    Atherosclerosis; 1976; 25(2-3):303-10. PubMed ID: 795441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.